Form 8-K - Current report:
SEC Accession No. 0000950170-24-129750
Filing Date
2024-11-21
Accepted
2024-11-21 16:38:16
Documents
12
Period of Report
2024-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cvsi-20241115.htm   iXBRL 8-K 64755
2 EX-99.1 cvsi-ex99_1.htm EX-99.1 15445
  Complete submission text file 0000950170-24-129750.txt   190392

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cvsi-20241115.xsd EX-101.SCH 22161
15 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20241115_htm.xml XML 4003
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

EIN.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54677 | Film No.: 241484999
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)